by Andrew Lo | Jul 14, 2022
Lita Nelsen serves as an advisor to QLS. Ms. Nelsen spent 30 years in the Technology Licensing Office of the Massachusetts Institute of Technology, 25 of them as director of the office. During that time, the MIT TLO licensed over 500 startup companies based on MIT...
by Andrew Lo | Jul 14, 2022
Dr. Robert Langer serves as an advisor to QLS and is one of 12 Institute Professors at the MIT; being an Institute Professor is the highest honor that can be awarded to a faculty member. He has written over 1,500 articles, which have been cited over 368,000 times; his...
by Andrew Lo | Jul 14, 2022
Dr. Larry Norton, M.D. is the Norna S. Sarofim Chair of Clinical Oncology, Senior Vice President in the Office of the President, and Deputy Director for Clinical and Translational Science in the Memorial Sloan Kettering Cancer Center, New York and serves as an advisor...
by Andrew Lo | Jul 14, 2022
Dr. Richard H. Scheller joined BridgeBio Pharma as chairman of R&D in 2019, having served as a member of the board since 2018. In addition, he serves on the board of directors at 23andMe, Alector, Maze Therapeutics, DiCE Molecules, and Aarvik Therapeutics, is on...
by Andrew Lo | Jul 14, 2022
Dr. Phillip A. Sharp is an Institute Professor at the Massachusetts Institute of Technology and member of the Department of Biology and the Koch Institute for Integrative Cancer Research and is an advisor to QLS. He joined the Center for Cancer Research (now the Koch...
Recent Comments